Samuel Short

University of Vermont — United States

Medicine · Health Sciences

17h-index3.9kcitations51works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(10), Sepsis Diagnosis and Treatment(7), Atrial Fibrillation Management and Outcomes(5), Venous Thromboembolism Diagnosis and Management(5), Dialysis and Renal Disease Management(5)

Publications42 total

Circulating biomarkers and ischemic stroke risk in adults with atrial fibrillation taking anticoagulation: the Reasons for Geographic And Racial Differences in Stroke study
Journal of Thrombosis and Haemostasis·2025· 1 citedOpen Access
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Journal of Thrombosis and Haemostasis·2025· 4 citedOpen Access
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
UNC Libraries·2025Open Access
Abstract P3005: Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation
Circulation·2025
Abstract P3009: Biomarkers and Risk of Cognitive Impairment in Atrial Fibrillation: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort
Circulation·2025
Abstract P3077: Pro-Enkephalin A and Risk of Incident Hypertension: The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
Circulation·2025
Plasma proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort
UNC Libraries·2024Open Access
Derivation of a Simple Risk Model for Cardiac Surgery-Associated AKI
Journal of the American Society of Nephrology·2024
Endothelial Dysfunction Biomarkers and CKD Incidence in the REGARDS Cohort
Kidney International Reports·2024· 10 citedOpen Access
Abstract 54: Circulating Biomarkers and Anticoagulation Breakthrough Stroke Risk in Atrial Fibrillation: The REGARDS Study
Circulation·2024· 2 cited
Plasma proenkephalin A and incident chronic kidney disease and albuminuria in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort
BMC Nephrology·2024· 4 citedOpen Access
Abstract 11396: Circulating Biomarkers Improve ChA <sub>2</sub> DS <sub>2</sub> -VASC Risk Prediction in Atrial Fibrillation: The CHA <sub>2</sub> DS <sub>2</sub> -VASc-Biomarkers Model
Circulation·2023
AKI treated with kidney replacement therapy in critically Ill allogeneic hematopoietic stem cell transplant recipients
Bone Marrow Transplantation·2023· 6 cited
Platelet Factor 4 Antibodies and Severe AKI
Kidney360·2023· 1 citedOpen Access
Alternatives to single-use plastics in food packaging and production
2023
Plasma Pro‐Enkephalin A and Incident Cognitive Impairment: The Reasons for Geographic and Racial Differences in Stroke Cohort
Journal of the American Heart Association·2023· 3 citedOpen Access
The Evolution of personalised nutrition
2023· 1 citedOpen Access
Platelet Count Is a Novel Independent Predictor of Major Adverse Kidney Events
Journal of the American Society of Nephrology·2022
AKI Treated With Kidney Replacement Therapy in Allogeneic Hematopoietic Stem Cell Transplantation (aHSCT) Patients Admitted to the Intensive Care Unit: Incidence, Risk Factors, and Outcomes
Journal of the American Society of Nephrology·2022
Platelet Factor 4 Antibodies and Severe AKI
Journal of the American Society of Nephrology·2022
page 1 of 3Next →

Frequent Co-authors

David E. Leaf(16), Mary Cushman(14), Katherine Wilkinson(13), Shruti Gupta(11), Samantha K. Brenner(10), Shahzad Shaefi(10), Lili Chan(9), Chirag R. Parikh(9), Sushrut S. Waikar(9), Salim S. Hayek(8), Kusum S. Mathews(8), Anand Srivastava(8), Adam Green(8), Alexandre M. Shehata(8), Miguel A. Hernán(8), Virginia J. Howard(8), Amanda K. Leonberg‐Yoo(7), Zoé A. Kibbelaar(7), Janin Schulte(7), George Howard(7)